Pixel Watch users report inflated steps, calories, and missing health data after the March 2026 update, raising concerns about tracking reliability and leaving many waiting for a fix.

At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people with diabetes.

Perplexity Health connects your lab results, prescriptions, and wearable data in one place, giving you health answers that are backed by real medical sources.

AI company Perplexity today introduced Perplexity Health, a suite of connectors that allow Perplexity to access your health ...

Defense Unicorns, a provider of airgap-native technologies, and the US Air Force Sustainment Center (AFSC) Software Directorate have completed a demonstration enabling rapid software installation and ...

A powerful new real-world data platform could transform how scientists predict and understand Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD), reports a new study at Columbia ...

Dexcom ( (DXCM)) just unveiled an update. On February 26, 2026, Dexcom’s board expanded to twelve members and appointed Rick Osterloh, Google’s Senior Vice President for Platforms & Devices, as an ...

The S&P 500 closed barely higher on ⁠Friday, ⁠supported by cooling inflation data, but the Nasdaq ⁠ended lower as heavyweight technology and communications services shares lost ground on nagging fears ...

Feb 12 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab beat Wall Street estimates for fourth-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...

Here's a look at the details in the report. The Details: DexCom reported quarterly earnings of 68 cents per share, which beat the Street estimate of 65 cents, according to data from Benzinga Pro.

People have been riding the GLP-1 wave to achieve quick and significant weight loss. But given the drug’s effect on controlling type 2 diabetes, it’s no surprise that DexCom CEO Jake Leach wants to ...